Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (not Streamex Corp.) on May 29, 2020, covering the event date of May 28, 2020. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a Current Report regarding a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
The material change reported is a corporate governance appointment. On May 28, 2020, Michael R. Dougherty was appointed to the board of directors of ViralClear Pharmaceuticals, Inc., a majority-owned subsidiary of BioSig Technologies, Inc.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items beyond the board appointment.
Investor Verification Checklist
- Verify the appointment of Michael R. Dougherty to the ViralClear Pharmaceuticals, Inc. board via the press release filed as Exhibit 99.1.
- Confirm the subsidiary relationship between BioSig Technologies, Inc. and ViralClear Pharmaceuticals, Inc.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.